GH Research (GHRS) Interest Expenses (2021 - 2025)
GH Research (GHRS) recorded quarterly Interest Expenses of $836000.0 in Q4 2025, up 4080.95% quarter-over-quarter from -$21000.0 in Q3 2025, and down 33.39% on a YoY basis from $1.3 million in Q4 2024.
GH Research (GHRS) Interest Expenses (2021 - 2025) Analysis & Trends
GH Research's Interest Expenses history runs 5 years deep, the most recent figure standing at $836000.0 for Q4 2025.
- In Q4 2025, Interest Expenses fell 33.39% year-over-year to $836000.0; the TTM figure through Dec 2025 stood at $463000.0 (down 56.93% YoY), while the FY2025 annual figure was $463000.0, down 35.43% from the prior year.
- Interest Expenses was $836000.0 for Q4 2025 at GH Research, up from -$21000.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $1.3 million in Q4 2023 to a low of -$184000.0 in Q3 2023.
- Historically, Interest Expenses has averaged $158333.3 across 5 years, with a median of -$21000.0 in 2025.
- The sharpest annual moves came in 2023 and 2025: Interest Expenses surged 921.95% in 2023, then plunged 199.44% in 2025.
- A 5-year view of Interest Expenses shows it stood at -$3000.0 in 2021, then soared by 4200.0% to $123000.0 in 2022, then soared by 921.95% to $1.3 million in 2023, then decreased by 0.16% to $1.3 million in 2024, then plunged by 33.39% to $836000.0 in 2025.
- The last three Interest Expenses figures came in at $836000.0 (Q4 2025), -$21000.0 (Q3 2025), and -$174000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 61,000.00 |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | -332,000.00 |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -5.58 Mn |
| 10 | GH Research | 9.73 Bn | 9.63 Bn | - | 836,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 836,000.00 |
| Dec 31, 2025 | 836,000.00 |
| Sep 30, 2025 | -21,000.00 |
| Sep 30, 2025 | -21,000.00 |
| Jun 30, 2025 | -174,000.00 |
| Jun 30, 2025 | -174,000.00 |
| Mar 31, 2025 | -178,000.00 |
| Mar 31, 2025 | -178,000.00 |
| Dec 31, 2024 | 1.26 Mn |
| Dec 31, 2024 | 1.26 Mn |
| Sep 30, 2024 | -181,000.00 |
| Sep 30, 2024 | -181,000.00 |
| Jun 30, 2024 | -178,000.00 |
| Jun 30, 2024 | -178,000.00 |
| Mar 31, 2024 | 179,000.00 |
| Mar 31, 2024 | 179,000.00 |
| Dec 31, 2023 | 1.26 Mn |
| Dec 31, 2023 | 1.26 Mn |
| Sep 30, 2023 | -184,000.00 |
| Sep 30, 2023 | -184,000.00 |